Pulsative flushing as a strategy to prevent bacterial colonization of vascular access devices

Agnès Ferroni, Florian Gaudin, Gérard Guiffant, Patrice Flaud, Jean-Jacques Durussel, Philippe Descamps, Patrick Berche, Xavier Nassif, Jacques Merckx, Agnès Ferroni, Florian Gaudin, Gérard Guiffant, Patrice Flaud, Jean-Jacques Durussel, Philippe Descamps, Patrick Berche, Xavier Nassif, Jacques Merckx

Abstract

Central venous device infections are associated with increased physical and psychological morbidity, mortality, length of stay, and costs. The aim of this study was to prove the efficacy of pulsatile flushing to prevent the bacterial colonization of vascular access devices. One hundred and forty four tests using 576 polyurethane short venous access catheters were performed. Four catheters per test were polluted with a fibronectin-serum albumin solution. Three were filled with a Staphylococcus aureus broth; one served as negative control. One contaminated catheter was not flushed (positive control), and two were flushed (10 mL.sec(-1)) with normal saline solution, either by ten successive boluses of 1 mL each or by one bolus of 10 mL. Each catheter was cultivated. The S. aureus quantity observed after continuous flushing was significantly higher than that observed after pulsative flushing (P<0.001). Unflushed catheters were 20.71 and 6.42 times more polluted than catheters flushed with the pulsative method or the continuous method, respectively. Pulsative flushing was at least twice as effective as continuous flushing in reducing the S. aureus count. Pulsative flushing is more effective than continuous flushing in reducing the endoluminal contamination. Pulsative flushing is a simple, effective, and inexpensive technique to reduce catheter bacterial colonization.

Keywords: bacterial colonization prevention; hydrodynamics; peripheral or central venous devices; pulsative flushing.

Figures

Figure 1
Figure 1
Design of the protocol. Abbreviations: FN, fibronectin; BSA, bovine serum albumin; CFU, colony forming units; S. aureus, Staphylococcus aureus.
Figure 2
Figure 2
Histogram of contamination per flushing treatment. Abbreviation: CFU, colony forming units.

References

    1. O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infection. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, US. Pediatrics. 2002;110:e51.
    1. Coello R, Charlett A, Ward V, et al. Device-related sources of baacteraemia in English hospitals – opportunities for prevention of hospital-acquired bacteraemia. J Hosp Infect. 2003;53(1):46–57.
    1. Percival SL, Kite P. Intravascular catheters and biofilm control. J Vasc Access. 2007;8:69–80.
    1. Adams JM, Speer ME, Rudolph A. Bacterial colonization of radial artery catheters. Pediatrics. 1980;65:94–97.
    1. Fletcher S. Catheter-related bloodstream infection. Contin Educ Anaesth Crit Care Pain. 2005;5:49–51.
    1. Coopersmith CM, Zack JE, Ward MR, et al. The impact of bedside behavior on catheter-related bacteremia in the intensive care unit. Arch Surg. 2004;139:131–136.
    1. Jeffries HE, Mason W, Brewer M, et al. Prevention of central venous catheter–associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol. 2009;30:645–651.
    1. Société Française d’Hygiène Hospitalière Prévention des infections associées aux chambres à cathéter implantables pour accès veineux. Hygiènes. 2012;XX:1.
    1. Guiffant G, Durussel JJ, Merckx J, Flaud P, Vigier JP, Mousset P. Flushing of intravascular access devices (IVADs) – efficacy of pulsed and continuous infusions. J Vasc Access. 2012;13(1):75–77.
    1. Pellenc D, Berry H, Gallet O. Adsorption-induced fibronectin aggregation and fibrillogenesis. J Colloid Interface Sci. 2006;298(1):132–144.
    1. Royon L, Durussel JJ, Merckx J, Flaud P, Vigier JP, Guiffant G. The fouling and cleaning of venous catheters: a possible optimization of the process using intermittent flushing. Chem Eng Res Des. 2012;90(6):803–807.
    1. Wadström T. Molecular aspects on pathogenesis of wound and foreign body infections due to staphylococci. Zentralbl Bakteriol Mikrobiol Hyg A. 1987;266(1–2):191–211.
    1. Walz JM, Memtsoudis SG, Heard SO. Prevention of central venous catheter bloodstream lnfections. J Intensive Care Med. 2010;25(3):131–138.
    1. Managing bloodstream infections associated with intravascular catheters. Drug Ther Bull. 2001;39:75–80. [No authors listed]
    1. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009;11(7):1034–1043.
    1. Horbett TA. The role of adsorbed proteins in animal cell adhesion. Colloids Surf B Biointerfaces. 1994;2(1–3):225–240.
    1. Potts JR, Campbell ID. Fibronectin structure and assembly. Curr Opin Cell Biol. 1994;6(5):648–665.
    1. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis. 2001;33:1567–1572.
    1. Russel PB, Kline J, Yoder MC, Polin RA. Staphylococcal adherence to polyvinyl chloride and heparin-bonded polyurethane catheters is species dependent and enhanced by fibronectin. J Clin Microbiol. 1987;25(6):1083–1087.
    1. Nemet B, Zagar Z. Fibronectin concentrations in catheter sepsis. Clin Microbiol Infect. 2000;6(3):121–124.
    1. Vaudaux P, Pittet D, Haeberli A, et al. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis. 1993;167(3):633–641.
    1. Vaudaux P, Waldvogel FA, Morgenthaler JJ, Nydegger UE. Adsorption of fibronectin on polymethylmethacrylate and promotion of Staphylococcus aureus adherence. Infect Immun. 1984;45:62–73.
    1. Vaudaux P, Lew DP, Waldvogel FA. Host factors predisposing to foreign body infections. In: Bisno AL, Waldvogel FA, editors. Infections Associated With Indwelling Medical Devices. Washington, DC: American Society for Microbiology; 1989. pp. 3–26.
    1. Hadaway L. Flushing vascular access catheters: Risks for infections transmission. Infection Control Resource. 2007;4(2):1–8.
    1. Hadaway L. Technology of flushing vascular access devices. J Infus Nurs. 2006;29:137–145.
    1. Hadaway L. Flushing to reduce catheter occlusions. Nursing. 2000;30:74.
    1. Bertoglio S, Rezzo R, Merlo FD, et al. Pre-filled normal saline syringes to reduce totally implantable venous access device-associated bloodstream infection: a single institution pilot study. J Hospital Infect. 2013;84:85–88.
    1. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7:277–281.
    1. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002;8(9):881–890.
    1. Donlan RM. Biofilm elimination on intravascular catheters: important considerations for the infectious diseases practitioner. Clin Infect Dis. 2011;52(8):1038–1045.
    1. Guiffant G, Durussel JJ, Flaud P, Royon L, Marcy PY, Merckx J. Power port contrast medium flushing and trapping: impact of temperature, an in vitro experimental study. Med Devices (Auckl) 2013;6:133–140.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner